Development of the urokinase plasminogen activator/SCID (uPA/SCID) transgenic mouse model has opened new perspectives for the study of different biological mechanisms such as liver regeneration, stem cell differentiation, and human hepatic pathogens. We observed that homozygous uPA/SCID mice (uPA +/+ /SCID) had a small offspring, indicating a fertility defect. The goal of this study was thus to rescue the fertility of homozygous uPA mice. A deregulation of ovarian function with an absence of corpus luteum was observed in female uPA +/+ /SCID mice. In male uPA +/+ /SCID mice, a decrease of the weight of the testes, epididymis, seminal vesicle, and prostate was measured. This was associated with an absence of seminal and prostatic secretions and a reduction in testicular sperm production. We hypothesized that the infertility of mice was the consequence of uPA-induced liver injury. Thus, in order to rescue liver function, hepatocytes from mice negative for the uPA transgene were transplanted into uPA +/+ /SCID mice. Thirty days after cell transplantation, the livers of transplanted uPA +/+ /SCID mice were totally repopulated and presented a normal morphology. Furthermore, transplantation restored normal body weight, life span, and reproductive organ function.
INTRODUCTION
Hepatitis B virus (HBV), hepatitis C virus (HCV), and Plasmodium are the three major hepatic pathogens and each year cause close on 10 million deaths through-Urokinase-type plasminogen activator (uPA) transgenic mice were first described in 1990 by Heckel et al. out the world. These pathogens require fully functional human hepatocytes for their development. Unfortu- (16) . The overexpression of uPA protein in hepatocytes results in the activation of plasminogen to plasmin, which nately, hepatoma cell lines are difficult to infect and primary hepatocytes in culture do not retain their differenti-is cytotoxic and gives rise to a continuous liver regeneration process (8) . Under these conditions, hepatocytes ated function, thus limiting the value of these in vitro models. In vivo, the lack of a small-animal model sus-that lose the transgene by somatic reversion, as well as healthy transplanted hepatocytes, have a strong survival ceptible to infection by human hepatotrope pathogens has hampered the development of simple methods to advantage over resident cells (32, 33, 35) . The uPA/SCID mouse model has rapidly become an essential model for evaluate new therapeutic compounds. uPA transgenic mice were backcrossed on an immunodeficient back-the study of different biological mechanisms such as liver regeneration (3, 35, 42, 43) , carcinogenesis (34) , cell ground (SCID or RAG-2 mice) to obtain a mouse model that would tolerate the xenotransplantation of rat, wood-differentiation (6, 17, 36) , and human hepatic pathogens. 804 BREZILLON ET AL. chuck, tupaia, and human hepatocytes (9,10,30,31,33, Breeding was performed by coupling one male with one or two female mice. Animals were weighed between 38). The functionality of transplanted hepatocytes was later attested by their susceptibility to infection with 1000 and 1100 h at the ages indicated. All animals were maintained under pathogen-free conditions and were HBV (11, 26, 37, 39) , HCV (25, 26, 40, 41) , and Plasmodium falciparum (28) . treated in accordance with European Union regulations on animal care. Different research groups have developed strategies to improve human hepatocyte transplantation in terms Hepatocyte Transplantation Procedure of human hepatocyte survival. A first approach was to improve transplant duration by inducing a depletion of Primary hepatocytes were isolated from 60-day-old macrophages and NK cells (28) . In parallel, Tateno et Balb/c mice, as previously described (15). Cell viability al. reported lethality in mice when the human hepatocyte was determined by trypan blue exclusion. Hepatocytes replacement index exceeded 50%; they proposed rescue were resuspended in William's medium E + GlutaMAX of the animals using anti-human complement factor (GIBCO, France) and then 3 × 10 5 cells, of at least 90% treatment (38). Finally, the homozygosity of the uPA viability, were transplanted into the spleen of 30-daytrait was reported to be critical to the successful estabold uPA +/+ /SCID mice (13). lishment of infection. Indeed, a substantial advantage in terms of both the magnitude and duration of human he-Estrous Cycle Examinations patocyte engraftment was observed in homozygous uPA
The estrous cycles of 75-day-old uPA/SCID female recipients compared with heterozygous counterparts mice were monitored through daily histological analyses (25) . This observation is linked to spontaneous loss (in of vaginal smears. The vaginal cavity was washed using heterozygous mice) of the uPA transgene, which ensures 20 µl PBS and cells smeared onto a clean glass slide. repopulation of the liver by cured hepatocytes. Thus, the The stage of the estrous cycle was determined from the outcome of a human hepatocyte graft is dependent on cell types observed in the vaginal smear. The estrous the presence of the uPA transgene on both alleles. To cycle was determined as the interval between the onset increase the number of homozygous mice for the uPA of one estrous and the next estrous event. The total numtransgene to be transplanted, and to avoid analyses of ber of estrous cycles was recorded over a period of 22 zygosity, we thus bred homozygous mice for the uPA consecutive days of examination. and SCID traits. Unexpectedly, there was very few offspring, indicating the presence of a fertility defect.
Organs' Recovering and Staining Protocol The objective of this study was to characterize this Mice were sacrificed by cervical dislocation, and the hypofertility and to rescue it. We hypothesized that the organs of interest were recovered, weighed, and fixed. infertility in these mice was a consequence of uPA-
The ovaries and liver were removed, placed in formalin induced liver injury. We therefore decided to perform and then embedded in paraffin wax, serially sectioned at hepatocyte transplantation first of all, in order to restore 5 µm, and stained either with hematoxylin, eosin, and normal liver function, and then to verify the impact of Safran (HES) or with silver (for reticulin visualization). this transplantation on the reproductive organs.
Ovarian sections were examined for the presence of follicles and corpora lutea. For male fertility analyses, the MATERIALS AND METHODS fixation of reproductive organs and accessory glands was performed in DF2 fixative (35% ethanol, 10% ace-Animals tic acid, 2% formaldehyde) at room temperature for 24 Alb-uPA mice were purchased from Jackson Laborah. Histological examinations were performed under the tory (Bar Harbor, ME, USA), SCID mice came from microscope using an Eclipse 600 Nikon microscope. Charles River Laboratories (Lyon, France). The generation of Alb-uPA/SCID mice has been described pre-Examination of Testes, Male Accessory Glands, viously (28) . Briefly, the original heterozygous Alb-uPA and Spermatozoa transgenic mice were obtained on a C57BL/6 genetic background; mice heterozygous for the uPA transgene Sexually mature male mice (10-17 weeks of age), never exposed to females, were used to phenotype repro-and homozygous for the SCID mutation (uPA +/− /SCID) were obtained after multiple back-crosses of heterozy-ductive traits. Epididymal sperm counts and functional sperm examinations were performed as previously de-gous Alb-uPA transgenic mice with mice on a CBϳ17 genetic background containing the homozygous SCID scribed (21) . The mean size of seminiferous tubules was assessed by measuring diameters of 20 round transversal mutation. The presence on one or both alleles of the uPA transgene and SCID trait was attested by PCR (27) .
tubule sections per animal. Figure 2A and B. At 30 days of age, significant differences were observed in Statistical analyses were performed using the Statview the weight of animals. Indeed, both female and male 5.0 software. Data sets were compared using analysis of mice displayed significant weight loss as a function variance t-tests. Data are represented as means ± SD. Unof their uPA genotype (uPA −/− /SCID > uPA +/− /SCID > less otherwise noted, value of p < 0.05 was considered as uPA +/+ /SCID). As transplantation occurred at day 30, no significant.
Statistical Analyses and male body weight is shown in
differences were observed between the weight of non-
RESULTS
transplanted uPA +/+ /SCID mice and transplanted uPA +/+ / Effect of Hepatocyte Transplantation on the Liver SCID mice. At 60 days (30 days after transplantation), Development of uPA +/+ /SCID Mice the body weight of tr-uPA +/+ /SCID mice was significantly higher than that of uPA +/+ /SCID mice (15.1 ± 1.75 The liver development of uPA +/− /SCID mice, uPA +/ vs. 11.6 ± 2.63 g, p = 0.0005 for females, and 17.9 ± + /SCID mice, and uPA +/+ /SCID mice transplanted with 2.23 vs. 10 ± 2.23 g, p = 0.006 for males). The differhealthy mouse hepatocytes (tr-uPA +/+ /SCID) was anaence between tr-uPA +/+ /SCID and uPA +/+ /SCID mice lyzed at 30, 47, 60, and 90 days after birth, in order to persisted at days 90 and 120. study the hepatotoxicity of uPA transgene expression
The viability of uPA +/− /SCID, uPA +/+ /SCID, and tr-( Fig. 1A ). As previously reported, the liver of uPA het-uPA +/+ /SCID mice was followed over a 6-month period erozygous mice exhibited the typical evolution from a ( Fig. 2C ). Six percent mortality was observed in uPA +/− / white appearance, followed by the formation of regener-SCID mice, whereas mortality rose to up to 50% in ative nodules that gradually expanded and repopulated uPA +/+ /SCID mice. Interestingly, transplanted tr-uPA +/+ / the entire liver around 8 weeks after birth. During the SCID mice presented viability that was similar to that same period of time, a persistence of smooth, pale to of uPA +/− /SCID heterozygous mice. Thus, transplantanearly white liver was observed in uPA homozygous tion was able to restore a satisfactory viability of uPA +/+ mice. By contrast, from 17 days after transplantation, /SCID homozygous mice. Taken together, these results tr-uPA +/+ /SCID mice exhibited liver repopulation with confirmed that the rescue of liver function by primary healthy hepatocytes, as demonstrated by the formation mouse hepatocyte transplantation was associated with of a red area. At day 60, the liver of tr-uPA +/+ /SCID the restoration of normal mouse development in terms mice was totally repopulated and presented no macroof body weight and life span. scopic differences from the liver of uPA −/− /SCID or uPA +/− /SCID control mice ( Fig. 1A) . After HES staining, Effect of Hepatocyte Transplantation on the Fertility the liver was examined histologically in order to analyze of Homozygous uPA +/+ /SCID Mice the lobular morphology of 90-day-old mice. As pre-
The offspring resulting from a 6-month follow-up of viously reported, uPA +/+ /SCID livers presented numerbreeding are summarized in Table 1 . The mating of 10 ous multifocal regenerative foci made up of several lobcouples of uPA heterozygous female and male mice ules, and most of the hepatic lobules appeared to be gave rise to an average of 14 ± 4 newborns per couple disorganized (data not shown). Reticulin staining en-(3.6 litters/female and 3.8 pups/litter). Notably, we obabled better visualization of this mild lobular disorganiserved that this breeding led to a Mendelian distribution zation (Fig. 1B) . In tr-uPA +/+ /SCID mice, we were able of the three genotypes (46% uPA −/− , 27% uPA +/− , 27% to observe numerous and diffuse small nodules of regen-uPA +/+ , 535 mice tested). By contrast, the 6-month erative hepatic foci made up of one small lobule orgabreeding period of 10 couples of uPA homozygous fenized around the terminal hepatic vein with centrifuge male and male mice produced just 4 newborns from one hepatocyte trabeculae and peripheral portal spaces ( Fig. couple only. We investigated whether the mating of uPA 1B). In conclusion, livers from tr-uPA +/+ /SCID mice, heterozygous female with uPA homozygous male mice, after hepatocyte transplantation, exhibited the same and vice versa, could rescue normal fertility. In both macroscopic phenotype and the same lobular organizacases, no pregnancies were achieved during the 6-month tion as those from uPA +/− /SCID or uPA −/− /SCID control follow-up of these couples. By contrast, the breeding of mice.
females with male tr-uPA +/+ /SCID mice resulted in 13 ± Effect of Hepatocyte Transplantation on the Weight 3 newborns per couple (3.5 litters/female and 3.8 pups/ and Life Span of uPA +/+ /SCID Mice litter) and 100% homozygous uPA animals. It is thus clear that the zygosity of the uPA transgene exerts a We investigated the general impact of the uPA trait on body weight and life span and evaluated the conse-strong impact on litter size, as well as the transplantation approach restores the possibility of a full-term preg-quences of mouse hepatocyte transplantation on uPA +/+ / SCID. The impact of uPA transgene zygosity on female nancy with normal litter size. Effect of Hepatocyte Transplantation on the Ovarian tion dysregulation (Fig. 3A) . Hepatocyte transplantation restored the capacity to produce a regular estrous cycle Function of uPA +/+ /SCID Mice even if the mean length of each cycle was 12% more in tr-uPA +/+ /SCID mice than in uPA +/− /SCID control mice In order to dissect the primary ovarian defect in uPA +/+ /SCID mice, we evaluated the population of ovarian fol-(7.2 days/cycle vs. 6.3 days/cycle). Furthermore, no significant differences were observed when comparing the licles and follicular development. Estrous cycles were verified by inspecting daily vaginal smears over 3 con-number of estrous events in tr-uPA +/+ /SCID mice with their control uPA +/− /SCID mice (3 vs. 3.5), as well as secutive weeks. Sexually mature uPA +/− /SCID mice displayed regular estrous cycles and normal mating be-the length of each phase of the cycle (Fig. 3B) . From examination of all genotype categories by his-haviors, whereas none of the uPA +/+ /SCID females showed any evidence of normal estrous cycles, a dies-tological analysis of the ovaries, it became clear that at 3 months of age, ovary size was significantly reduced trous type pattern with persistent leukocyte infiltration being observed, which was reminiscent of ovarian func-in uPA +/+ /SCID mice (Fig. 3C ). No corpus luteum was detectable, indicating an absence of ovulation. Interest-Effect of Hepatocyte Transplantation on the Reproductive Organs of uPA +/+ /SCID Male Mice ingly, following hepatocyte transplantation, tr-uPA +/+ / SCID ovaries recovered a normal size and a normal follicular distribution, with the presence of numerous cor-To explore the infertility of uPA +/+ /SCID male mice we evaluated testes, accessory gland development, and pora lutea. Thus, the transplantation procedure was effective in restoring the fertility of uPA +/+ /SCID mice, spermatogenesis (Fig. 4) . In uPA +/+ /SCID male mice, a reduction of about 43% was seen in the weight of the notably by reversing the deleterious ovarian phenotype. genic line and mutations leading to an adaptation to the uPA trait and/or a reduction in the number of transgene copies in tandem in the mouse genome. The infertility of female mice was associated with a deleterious pheno-testes (p = 0.0009), 54% of the epididymis (p = 0.0004), 84% of the seminal vesicles (p = 0.00008), and 74% of type in ovaries, which led to an absence of normal estrous cycles. In males, histological abnormalities regard-the prostate (p = 0.0003) when compared to control animals (data from uPA −/− /SCID and uPA +/− /SCID mice ing the testes and accessory glands, associated with an absence of seminal and prostatic secretions and low were pooled, as no significant differences were observed regarding these parameters) (Fig. 4A ). With the excep-spermatozoid numbers were the reasons for infertility.
We have thus demonstrated that a transplantation ap-tion of the testes, significant results were obtained when the data were expressed as a ratio to the body weight of proach using healthy hepatocytes led to the restoration of normal liver morphology and life span, and a return mice (data not shown). We further examined the development of testes and accessory glands histologically in to function for both male and female reproductive organs. all genotypes (Fig. 4B) . In testes, no gross abnormalities affected the germinative epithelium or interstitial tissues.
The regulation of the uPA/uPA inhibitor system has been reported to play a role in mammalian reproduction However, in uPA +/+ /SCID mice, the mean diameter of seminiferous tubules was significantly smaller than processes through its involvement in ovarian physiology (23) and spermatogenesis (19, 22, 24, 45, 46) . In this con-those found in control animals (148 ± 10 µm vs. 169 ± 8 µm, p = 0.0006). In uPA +/+ /SCID mice, a histological text, two nonexclusive hypotheses could be proposed to directly implicate uPA expression in the dysregulation analysis of seminal vesicles and prostate glands revealed a reduction in the size of both glands, associated with an of reproductive organ function: firstly, and despite a liver specific promoter, ectopic expression of the trans-absence of seminal and prostatic secretions. Hepatocyte transplantation in uPA +/+ /SCID mice restored normal tes-gene in reproductive organs, and secondly, a direct effect of circulating uPA transgenic protein. In order to tis weights and seminiferous tubule diameters as well as normal functions for the epididymis and seminal vesi-evaluate the first hypothesis, we verified the expression of the uPA transgene transcript using real-time RT-PCR. cles (Fig. 4) .
Sperm counts revealed that uPA +/+ /SCID mice had al-As expected, we observed no transgene expression in the ovaries or testes of uPA mice (data not shown). This most twice fewer spermatozoa than control mice (4 ± 0.7 × 10 6 vs. 7.3 ± 2.5 × 10 6 ; p = 0.03) (Fig. 4A ). Trans-result eliminated the possibility that infertility might be a consequence of uPA transgene expression in reproduc-plantation completely restored normal sperm production (9.5 ± 5 × 10 6 ). In addition, spermatozoal morphology tive organs. We were unable to exclude the possibility that mouse infertility might result from the direct effect and vitality, the rate of acrosome reaction, and sperm mobility were evaluated and exhibited no significant dif-of circulating uPA transgenic protein. Indeed, the normal fertility of either heterozygous uPA mice after so-ferences between the groups (data not shown).
Taken together, these results show that hepatocyte matic reversion or homozygous uPA mice after hepatocyte transplantation was concomitant with an absence of transplantation restored normal function to the male reproductive organs.
uPA transgenic transcript detection in the liver of these mice (data not shown). Because it was impossible to DISCUSSION dissociate uPA transgene expression from liver disease in this mouse model, final evidence for the toxicity of The uPA/SCID mouse model has rapidly become an essential to the study of different biological mechanisms the systemic uPA transgenic protein will be provided by analyzing the reproduction of animals that overexpress such as liver regeneration, stem cell differentiation, and human hepatic pathogens. Although spontaneous inacti-uPA but do not suffer from liver damage. We therefore believe that defective reproduction is vation of the transgene in heterozygous uPA mice may probably a consequence of general hepatic dysfunction, in order to assess a possible impact of IGF-1 modulation on fertility in our mouse model, we verified the expres-and that normal liver function can be rescued by somatic reversion as well as by hepatocyte transplantation. The sion of the IGF-1 transcripts in the liver, testes, and ovaries using real-time RT-PCR. No modulation of IGF-1 liver is a central organ in the growth hormone (GH)/ insulin-like growth factor-1 (IGF-1) axis. A number of expression was observed in any of the mice genotypes tested, suggesting that the infertility of uPA homozy-studies have demonstrated that female and male reproductive functions are affected by deregulation of the gous mice was not associated with a deregulation of IGF-1 expression (data not shown). However, we could GH/IGF-1 axis (7) . In parallel, it has been pointed out that liver cirrhosis may be characterized by high serum not exclude the possibility of GH or GH receptor expression impairment might have a direct effect on reproduc-GH levels and a parallel decrease in serum IGF-1 (5) . It has been reported that successful orthotopic liver trans-tion.
In the present article, we provide evidence that hepa-plantation enables a complete recovery of the GH/IGF-1 axis in patients with end-stage liver disease (1). Thus, tocyte transplantation therapy performed to restore liver function could also contribute to the recovery of normal of the limited availability of donor livers for orthotopic transplantation, alternative therapies, such as hepatocyte fertility. In humans, numerous pathologies such as Wilson's disease, α-1 antitrypsin deficiency, progressive in-transplantation, have been proposed. Initial clinical trials only reported a modest therapeutic effect in liver meta-trahepatic cholestasis, galactosemia, fructose intolerance deficiency, bile acid synthesis disorders, and peroxisomal bolic disorders such as Crigler Najjar (12), urea cycle (18), or GSD (29) . Development of this therapy is still biogenesis disorders may, as a final outcome, benefit from liver transplantation (14). For example, in the con-in its infancy, but strategies to enhance the efficacy of this approach in a mouse model were recently published text of glycogen storage disease (GSD), an association has been reported between liver dysfunction and fertility (4, 44) .
In conclusion, our study demonstrates that transplan-defects (20) . Furthermore, a normal pregnancy was recently described in a woman with GSD following com-tation in a mouse model of healthy hepatocytes to cure liver dysfunctions can restore normal reproductive capa-bined liver-kidney transplantation (2) . However, because 
